Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study

Abstract Background This is the first study, to our knowledge, to evaluate the ocular effects of an intranasal corticosteroid during 2 years of treatment for perennial allergic rhinitis (PAR). Objective To assess ocular safety in adult and adolescent patients 12 years and older with PAR after 2 year...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of allergy, asthma, & immunology asthma, & immunology, 2013-07, Vol.111 (1), p.45-50
Hauptverfasser:	LaForce, Craig, MD, Journeay, Glen E., MD, PhD, Miller, S. David, MD, Silvey, Mary Jane, MBA, Wu, Wei, PhD, Lee, Laurie A., MD, Chylack, Leo T., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Adolescent Adult Aged Allergy and Immunology Androstadienes - administration & dosage Androstadienes - adverse effects Androstadienes - therapeutic use Anti-Allergic Agents - administration & dosage Anti-Allergic Agents - adverse effects Anti-Allergic Agents - therapeutic use Cataract - chemically induced Child Double-Blind Method Epistaxis - chemically induced Female Humans Intraocular Pressure - drug effects Male Middle Aged Nasal Sprays Rhinitis, Allergic, Perennial - drug therapy Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!